Singapore markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7847+0.0247 (+1.42%)
As of 10:29AM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
449
420
0
0
0
Operating expenses
Research development
16,283
19,155
20,274
14,928
4,759
Selling general and administrative
6,655
6,718
7,382
7,461
5,877
Total operating expenses
22,938
25,873
27,656
22,389
10,636
Operating income or loss
-22,489
-25,453
-27,656
-22,389
-10,636
Total other income/expenses net
-390
-364
1,531
188
913
Income before tax
-22,727
-25,551
-25,915
-22,185
-9,681
Income tax expense
-3,030
-2,996
-4,717
-3,728
-1,236
Income from continuing operations
-19,697
-22,555
-21,198
-18,457
-8,445
Net income
-19,697
-22,555
-21,198
-18,457
-8,445
Net income available to common shareholders
-19,848
-22,756
-21,399
-18,658
-12,421
Basic EPS
-29.85
-26.75
-28.70
-32.10
-51.30
Diluted EPS
-29.85
-26.75
-28.70
-32.10
-51.30
Basic average shares
838.137
850.815
657.62
595.078
242.225
Diluted average shares
838.137
850.815
657.62
595.078
242.225